EDIL3 and breast carcinoma: Since EDIL3 interacts with integrin αVβ3 and other ligands of this integrin are secreted to the ECM and present an autocrine regulation mechanism, we investigated whether EDIL3 was secreted to the medium by breast cancer cells expressing different levels of EDIL3.